Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Abeona Therapeutics Inc.

    NASDAQ: ABEO · Real-Time Price · USD
    5.75
    -0.15 (-2.54%)
    At close: Jun 27, 2025, 3:59 PM
    5.75
    -0.09%
    After-hours: Jun 27, 2025, 05:50 PM EDT

    Abeona Therapeutics Statistics

    Share Statistics

    Abeona Therapeutics has 51.16M shares outstanding. The number of shares has increased by 18.48% in one year.

    Shares Outstanding

    n/a
    		 51.16M

    Shares Change (YoY)

    n/a
    		 18.48%

    Shares Change (QoQ)

    n/a
    		 11.65%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 45.31M

    Failed to Deliver (FTD) Shares

    n/a
    		 61

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 6.01M, so 11.75% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.01M

    Short % of Shares Out

    n/a
    		 11.75%

    Short % of Float

    n/a
    		 12.57%

    Short Ratio (days to cover)

    n/a
    		 4.56

    Valuation Ratios

    The PE ratio is -3.59 and the forward PE ratio is 42.61. Abeona Therapeutics's PEG ratio is 0.09.

    PE Ratio

    n/a
    		 -3.59

    Forward PE

    n/a
    		 42.61

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 5.19

    P/FCF Ratio

    n/a
    		 -3.91

    PEG Ratio

    n/a
    		 0.09
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Abeona Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.08, with a Debt / Equity ratio of 0.52.

    Current Ratio

    n/a
    		 6.08

    Quick Ratio

    n/a
    		 6.08

    Debt / Equity

    n/a
    		 0.52

    Debt / EBITDA

    n/a
    		 -0.36

    Debt / FCF

    n/a
    		 -0.39

    Interest Coverage

    n/a
    		 -15.26

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-468,632.35

    Employee Count

    n/a
    		 136

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 41.05% in the last 52 weeks. The beta is 1.55, so Abeona Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.55

    52-Week Price Change

    n/a
    		 41.05%

    50-Day Moving Average

    n/a
    		 5.92

    200-Day Moving Average

    n/a
    		 5.77

    Relative Strength Index (RSI)

    n/a
    		 45.63

    Average Volume (20 Days)

    n/a
    		 1,737,866

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -2.91M

    Operating Income

    n/a
    		 -64.21M

    Net Income

    n/a
    		 -63.73M

    EBITDA

    n/a
    		 -64.21M

    EBIT

    n/a
    		 -67.94M

    Earnings Per Share (EPS)

    n/a
    		 -1.55
    Full Income Statement

    Balance Sheet

    The company has 23.36M in cash and 23.05M in debt, giving a net cash position of 309K.

    Cash & Cash Equivalents

    n/a
    		 23.36M

    Total Debt

    n/a
    		 23.05M

    Net Cash

    n/a
    		 309K

    Retained Earnings

    n/a
    		 -813.26M

    Total Assets

    n/a
    		 99.36M

    Working Capital

    n/a
    		 70.14M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -56.02M and capital expenditures -2.45M, giving a free cash flow of -58.46M.

    Operating Cash Flow

    n/a
    		 -56.02M

    Capital Expenditures

    n/a
    		 -2.45M

    Free Cash Flow

    n/a
    		 -58.46M

    FCF Per Share

    n/a
    		 -1.42
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ABEO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ABEO is $19.5, which is 229.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $19.5

    Price Target Difference

    n/a
    		 229.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 5, 2022. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Jul 5, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 -9.22

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist